Player FM 앱으로 오프라인으로 전환하세요!
Meeting Unmet Needs of Neurodegeneration and Disorders of Cognition by Targeting the NMDA Receptor with Dr. Aaron Koenig and Mike Quirk Sage Therapeutics
Manage episode 288116584 series 99915
Dr. Aaron Koenig, Senior Medical Director and Mike Quirk, Vice President of pharmacology Sage Therapeutics focus on disorders of cognition and diseases that reflect determinants of impaired cognition such as Alzheimer's, Parkinson's and Huntington's. Their drug Sage-718, a novel mechanism of action, targets a protein in the brain, the NMDA receptor, thought to be the brain's coincidence detector designed to link together information that flows from different neural pathways and perhaps correct some of the symptoms causing functional impairment.
@SageBiotech #Alzheimers #Parkinsons #Huntingtons #executivefunction #cognition #neurodegeneration
1733 에피소드
Manage episode 288116584 series 99915
Dr. Aaron Koenig, Senior Medical Director and Mike Quirk, Vice President of pharmacology Sage Therapeutics focus on disorders of cognition and diseases that reflect determinants of impaired cognition such as Alzheimer's, Parkinson's and Huntington's. Their drug Sage-718, a novel mechanism of action, targets a protein in the brain, the NMDA receptor, thought to be the brain's coincidence detector designed to link together information that flows from different neural pathways and perhaps correct some of the symptoms causing functional impairment.
@SageBiotech #Alzheimers #Parkinsons #Huntingtons #executivefunction #cognition #neurodegeneration
1733 에피소드
ทุกตอน
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.